Tag Archives: flu shot

Tips for reporting on what experts say could be a tough flu season for the elderly

Leave a reply

As cases of the Delta variant start to wane, infectious disease specialists have a new concern this fall — flu and pneumonia, especially in vulnerable populations like older adults.

Experts from the National Foundation for Infectious Diseases (NFID) and the CDC expressed concern about a potentially serious flu season at a video press briefing on October 7.  Flu cases during 2020-21 were extremely low— just 2,124 confirmed cases between Sept. 27, 2020, and May 15, 2021— thanks in large part to people working from home, wearing masks, social distancing and practicing good hand hygiene.

But as more communities ease restrictions, the flu could surge this year, impacting many more people. For seniors, whose immune systems are weaker than younger adults, that could mean an increase in hospitalizations, cases of pneumonia, or even deaths.

“The medical and public health community are preparing for a potentially vigorous respiratory virus session in the United States,” said William Schaffner, M.D., NFID medical director, who moderated the briefing. “The best way to prepare is to get your flu vaccine.”

Vaccination is especially important among at-risk populations, including adults 65 and older, and those with certain chronic conditions according to Schaffner.

Currently, the U.S. is on track for similar flu vaccination rates as 2020, about 52% overall, according to CDC director Rochelle Walensky, M.D., M.P.H., who participated in the briefing.  That rate may not be good enough this year to keep case rates low.

A recent NFID survey revealed that even among those who are at high risk for complications, nearly 1 in 4 (23%) were not planning to get vaccinated this season. While most people over age 65 (71%) said they will get a flu shot, 30% of seniors would remain unprotected, leading to potentially serious consequences.

Continue reading →

Liz Seegert (@lseegert), is AHCJ’s topic leader on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

How to cover the 2021-2022 flu season

Leave a reply

Photo courtesy of the CDC

As it does every fall, the CDC is urging Americans to get their annual flu shot. Last year, flu was rare because Americans stayed home and wore masks to prevent the spread of COVID-19. This lack of flu from 2020 to 2021 (flu season generally occurs between October and May) could mean a potentially severe season this coming winter, CDC director Rochelle Walensky, M.D., M.P.H, said.

“When there is an active flu season one year to another, then we have…some protective immunity from the season prior,” Walensky said at the Oct. 7 flu season media briefing co-hosted by the CDC and the National Foundation for Infectious Diseases (NFID) and several health providers. “We do not have a lot of protective immunity from last season and because of that, we are worried” about the most vulnerable populations including children, pregnant people and those 65 and older.

Last year, public health officials warned of a “twindemic” of both COVID-19 and the flu, but the worst of their fears did not materialize. Public health experts believe behavior restrictions implemented to prevent the spread of COVID-19 (i.e., social distancing, mask-wearing and online learning in schools) also prevented the spread of the flu. This year, with many of the COVID-19 restrictions lifted, the public health community is bracing for a surge.

Public health officials are concerned that possibly because of vaccine fatigue, 44% of Americans were either unsure or didn’t plan to get vaccinated against the flu, and 25% of them are at high risk from flu complications, according to this NFID survey.

“Frankly, we are alarmed by the large number of people who said they won’t get vaccinated,” said William Schaffner, M.D., NFID’s medical director and professor of preventive medicine and infectious diseases at the Vanderbilt University School of Medicine.

Continue reading →

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico, The Washington Post and other outlets.

What are the risks for older adults as flu season approaches?

Leave a reply
stock art for Flu Shot Risk

Photo: NIH Image Gallery via Flickr

Get your flu shot. Never, perhaps, has that advice been as important for older adults to act on as this year. As winter approaches, geriatricians and infectious disease experts are increasingly concerned about the effects of even a mild flu season on an already-vulnerable older adult population, especially those in long-term care facilities.

It’s been likened to “a perfect storm,” and sailing in “uncharted waters,” according to a recent editorial in Science magazine by Edward Bologna, director of the Center for Clinical Epidemiology and Population Health at the Marshfield Clinic Research Institute in Marshfield, Wisc., and Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota in Minneapolis. Cliches aside, the reality is we have no idea what to expect when the pandemic and flu season converge, especially without a proven COVID-19 vaccine that is safe and effective in the older population. Continue reading →

Liz Seegert (@lseegert), is AHCJ’s topic leader on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

BMJ wants raw data for all drug trials to be shared

1 Reply

Under the headline “We want raw data, now,” BMJ editor Fiona Godlee recounts the story of how BMJ had to pressure a drug company into releasing full study reports verifying their claims as to the effectiveness of oseltamivir (Tamiflu).

stats
Tamiflu. Photo by Richard Sunderland via Flickr.

Godlee says that researchers updating their Cochrane review of the drug “failed to verify claims, based on an analysis of 10 drug company trials, that oseltamivir reduced the risk of complications in healthy adults with influenza. These claims have formed a key part of decisions to stockpile the drug and make it widely available.”

Only after Roche was questioned by the BMJ and Channel 4 News did the manufacturer commit to making “full study reports” available. Godlee says that some questions remain, including how patients were recruited and why some neuropsychiatric adverse events were not reported.

Godlee argues that “it can’t be right that the public should have to rely on detective work by academics and journalists to patch together the evidence for such a widely prescribed drug,” saying that “Individual patient data from all trials of drugs should be readily available for scientific scrutiny.”

Andrew Van Dam of The Wall Street Journal previously worked at the AHCJ offices while earning his master’s degree at the Missouri School of Journalism.

Fluportal.org stays on top of H1N1

Leave a reply

While H1N1 seems to have peaked in many states – at least for now – Fluportal.org‘s resources to cover the pandemic are still growing. Recent highlights include tips for using American Public Media’s Public Insight Network (which we’ve mentioned before in conjunction with a ProPublica story on health care reform), a few interesting photos with creative commons licenses (like a collection of H1N1 street art).

streetpig
One of the creative commons licensed shots of H1N1 street art spotlighted by fluportal.org. Photo by Brazilian artist guitavares via Flickr.

Fluportal also has tackled some media ethics issues related to the outbreak, notably in a post where staff from PRI’s The World had to consider how to frame the German medical establishment’s reluctance to recommend the H1N1 vaccine. After all, they did not want to confuse listeners or have a negative impact on public health, but they also weren’t going to “censor” the sincere opinions of German doctors, even if they conflicted with CDC advice.

Related

Public broadcasters have H1N1 site for journalists

Andrew Van Dam of The Wall Street Journal previously worked at the AHCJ offices while earning his master’s degree at the Missouri School of Journalism.